Phase 1 Hereditary Hemorrhagic Telangiectasia (HHT) Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Recruiting
Phase 1
Topical TOR-582 Treatment of Epistaxis in HHT
EpistaxisHereditary Hemorrhagic Telangiectasia (HHT)
Columbia University27 enrolled1 locationNCT07667413
Recruiting
Phase 1
A Trial of TER-1754 in Patients With Hereditary Hemorrhagic Telangiectasia
Hereditary Hemorrhagic Telangiectasia (HHT)
Terremoto Biosciences Inc.90 enrolled1 locationNCT07255846